Clinical Trial Update: RCT of Efficacy and Safety of CP003 on CFS/ME or Post-COVID Fatigue [Phase 2, Phase 3]

View source ↗

Summary

A randomized controlled trial is planned to evaluate the efficacy and safety of CP003 in chronic fatigue syndrome and post-COVID fatigue, with Phase 2 and Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myalgic Encephalomyelitis Chronic Fatigue Syndrome
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• CP003

Snippet

Sponsor: The University of Hong Kong | Conditions: Chronic Fatigue Syndrome (CFS), Post-COVID ME/CFS | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING